Dear Chuck, the controversy over drugs pricing in America goes beyond EpiPen. All levels of the American healthcare system are affected, from medicine, to hospital costs to primary care. The EpiPen controversy has certainly renewed the conversation, but it goes far beyond just Mylan or Martin Shkreli.